Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Alexander P Miceli

Showing results (1-10 of 10) with videos related to

Pageof 1
Sort By:
Molecular and Cellular Biology|November 9, 2011
Hypergrowth mTORC1 signals translationally activate the ARF tumor suppressor checkpointAlexander P Miceli, Anthony J Saporita, Jason D Weber
Molecular and Cellular Biology|September 21, 2011
Identification of DHX33 as a mediator of rRNA synthesis and cell growthYandong Zhang, Jason T Forys, Alexander P Miceli, et al.
Biochimica Et Biophysica Acta|February 15, 2014
ARF tumor suppression in the nucleolusLeonard B Maggi, Crystal L Winkeler, Alexander P Miceli, et al.
Journal of the American Chemical Society|October 5, 2006
Generation of oxynitrenes and confirmation of their triplet ground statesWalter A Wasylenko, Naod Kebede, Brett M Showalter, et al.
Molecular Cancer Therapeutics|May 30, 2006
Pharmacologic inhibition of cyclin-dependent kinase 4/6 activity arrests proliferation in myoblasts and rhabdomyosarcoma-derived cellsRaya Saab, Jennifer L Bills, Alexander P Miceli, et al.
Molecular and Cellular Biology|December 12, 2007
A non-tumor suppressor role for basal p19ARF in maintaining nucleolar structure and functionAnthony J Apicelli, Leonard B Maggi, Angela C Hirbe, et al.
Oncotarget|February 10, 2018
Cancer immunogenomic approach to neoantigen discovery in a checkpoint blockade responsive murine model of oral cavity squamous cell carcinomaPaul Zolkind, Dariusz Przybylski, Nemanja Marjanovic, et al.
Proceedings of the National Academy of Sciences of the United States of America|June 8, 2021
Radiation-induced neoantigens broaden the immunotherapeutic window of cancers with low mutational loadsDanielle M Lussier, Elise Alspach, Jeffrey P Ward, et al.
Cell Reports|September 30, 2016
Truncating Prolactin Receptor Mutations Promote Tumor Growth in Murine Estrogen Receptor-Alpha Mammary CarcinomasObi L Griffith, Szeman Ruby Chan, Malachi Griffith, et al.
Nature|October 25, 2019
MHC-II neoantigens shape tumour immunity and response to immunotherapyElise Alspach, Danielle M Lussier, Alexander P Miceli, et al.
Pageof 1

Showing results (1-10 of 10) with videos related to

Sort By:
Pageof 1
Molecular and Cellular Biology|November 9, 2011
Hypergrowth mTORC1 signals translationally activate the ARF tumor suppressor checkpointAlexander P Miceli, Anthony J Saporita, Jason D Weber
Molecular and Cellular Biology|September 21, 2011
Identification of DHX33 as a mediator of rRNA synthesis and cell growthYandong Zhang, Jason T Forys, Alexander P Miceli, et al.
Biochimica Et Biophysica Acta|February 15, 2014
ARF tumor suppression in the nucleolusLeonard B Maggi, Crystal L Winkeler, Alexander P Miceli, et al.
Journal of the American Chemical Society|October 5, 2006
Generation of oxynitrenes and confirmation of their triplet ground statesWalter A Wasylenko, Naod Kebede, Brett M Showalter, et al.
Molecular Cancer Therapeutics|May 30, 2006
Pharmacologic inhibition of cyclin-dependent kinase 4/6 activity arrests proliferation in myoblasts and rhabdomyosarcoma-derived cellsRaya Saab, Jennifer L Bills, Alexander P Miceli, et al.
Molecular and Cellular Biology|December 12, 2007
A non-tumor suppressor role for basal p19ARF in maintaining nucleolar structure and functionAnthony J Apicelli, Leonard B Maggi, Angela C Hirbe, et al.
Oncotarget|February 10, 2018
Cancer immunogenomic approach to neoantigen discovery in a checkpoint blockade responsive murine model of oral cavity squamous cell carcinomaPaul Zolkind, Dariusz Przybylski, Nemanja Marjanovic, et al.
Proceedings of the National Academy of Sciences of the United States of America|June 8, 2021
Radiation-induced neoantigens broaden the immunotherapeutic window of cancers with low mutational loadsDanielle M Lussier, Elise Alspach, Jeffrey P Ward, et al.
Cell Reports|September 30, 2016
Truncating Prolactin Receptor Mutations Promote Tumor Growth in Murine Estrogen Receptor-Alpha Mammary CarcinomasObi L Griffith, Szeman Ruby Chan, Malachi Griffith, et al.
Nature|October 25, 2019
MHC-II neoantigens shape tumour immunity and response to immunotherapyElise Alspach, Danielle M Lussier, Alexander P Miceli, et al.
Pageof 1